These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 1346626)

  • 1. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF; Aloyo VJ; Qin ZH; Weiss B
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.
    Morris BJ; Höllt V; Herz A
    Neuroscience; 1988 May; 25(2):525-32. PubMed ID: 3041310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat.
    Angulo JA; Coirini H; Ledoux M; Schumacher M
    Brain Res Mol Brain Res; 1991 Sep; 11(2):161-6. PubMed ID: 1661813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists.
    Morris BJ; Hunt SP
    Neurosci Lett; 1991 Apr; 125(2):201-4. PubMed ID: 1831887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with pentazocine or SFK 10047 decrease proenkephalin mRNA levels in the rat striatum and nucleus accumbens.
    Angulo JA; Ledoux M; McEwen BS
    Neurosci Lett; 1991 Jan; 122(1):47-9. PubMed ID: 1647506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat.
    Angulo JA; Cadet JL; Woolley CS; Suber F; McEwen BS
    J Neurochem; 1990 Jun; 54(6):1889-94. PubMed ID: 1971007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study.
    Curran EJ; Watson SJ
    J Comp Neurol; 1995 Oct; 361(1):57-76. PubMed ID: 8550882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist.
    Caboche J; Vernier P; Julien JF; Rogard M; Mallet J; Besson MJ
    J Neurochem; 1991 Feb; 56(2):428-35. PubMed ID: 1824860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
    J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine.
    Cadet JL; Zhu SM; Angulo JA
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):59-67. PubMed ID: 1312206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain.
    Turchan J; Lasoń W; Budziszewska B; Przewłocka B
    Neuropeptides; 1997 Feb; 31(1):24-8. PubMed ID: 9574833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J; Pietraszek M; Dziedzicka-Wasylewska M
    Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.